MNKD

MANNKIND CORP

MANNKIND CORP (MNKD) has 15 SEC Form 4 filings (39 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 18, 2026.

Insiders have net sold $376K over the trailing 6 months.

  • Industry:Biotechnology
  • CEO:Michael E. Castagna
  • Employees:403
  • HQ:Danbury, CA, US
  • IPO:2004-07-28

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$376K

reported sales (SEC code S)

Unique Insiders

2

in the rolling window

Market Cap

$1.2B

latest known value

Source
Sale$98KJul 18SEC ↗
Sale$213KJul 18SEC ↗
Binder Steven B.First filing
Sale$56KMay 14SEC ↗
Thomson DavidFirst filing
Sale$10KMay 14SEC ↗

Related companies

MANNKIND CORP is in the Healthcare sector.